Marken
- Sector Services and Software
- Year invested 2006
- Location UK
- Status Realised
Marken is a specialist express logistics and support services provider to the biopharmaceutical industry.
Visit marken.com
Overview
Its services include the movement of biological samples on a global basis, the export of trial medication, vaccines and clinical trial material, regulatory advice, protocol support, cold-chain management and investigator liaison.
How we added value
- Delivered an ambitious growth strategy and achieved a growth rate of over 30%
- Increased operating margins through both revenue growth and cost savings
- Strengthened the management team and introduced sector expert, Mel Porter, to the board as NXD
- Leveraged 3i’s global network to support organic growth while actively seeking out bolt-on acquisitions
- Established operations in China
- Expanded US market share and targeted US-based pharma companies
3i managed to pre-empt what was going to be a highly competitive auction by the speed with which it completed its due diligence and was ready to execute a contract. 3i became the preferred acquirer with management, and was quickly able to conclude the deal.
Regulatory information
This transaction involved a recommendation of 3i Investments plc.